Jr A Charles Rowland

Affiliations

  • at Generation Bio Co. (GBIO), 2024-06-10
  • at Orchard Therapeutics Plc (ORTX), 2024-01-24
  • Director at Viking Therapeutics Inc. (VKTX), 2024-01-05
  • Director at Nabriva Therapeutics Plc (NBRV), 2022-08-04
  • Director at Blueprint Medicines Corp (BPMC), 2021-06-04
  • Director at Nabriva Therapeutics Plc (NBRV), 2017-06-28
  • Director at Vitae Pharmaceuticals Inc (VTAE), 2016-10-25
  • Director at Dnib Unwind Inc. (BIND), 2016-08-30
  • Director at Idenix Pharmaceuticals Inc (IDIX), 2014-08-05
  • Vp, Chief Financial Officer at Viropharma Inc (VPHM), 2014-01-29
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
GBIO $1.50 150,000 534,757 2023-12-04 Filing
GBIO $1.31 192,960 384,757 2023-12-01 Filing
GBIO $5.26 15,750 191,797 2022-09-19 Filing
GBIO $5.48 33,481 176,047 2022-09-16 Filing
GBIO $5.41 17,147 142,566 2022-09-15 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
VKTX $25.00 40,000 Director 30,000 2023-05-16 Filing
NBRV $0.18 8,496 Director 15,277 2022-08-01 Filing
NBRV $1.20 777 Director 23,773 2021-08-02 Filing
BPMC $117.82 10,909 Director 3,562 2020-12-17 Filing
BPMC $95.97 694 Director 3,562 2020-11-03 Filing